NAMSA, a medtech contract research organization, agreed to acquire ÅKRN Scientific Consulting, a clinical research and regulatory consulting firm. Financial terms are not disclosed. “We are thrilled to welcome ÅKRN to NAMSA. The organization is well-respected for their proficiency in European medical device regulations and providing exceptional clinical support to MedTech Sponsors. Adding them to our team will expand our depth of expertise, enabling us to meet the growing demand for safe, efficient clinical development and commercialization of life-changing medical products,” Christophe Berthoux, NAMSA CEO.